CD44 is a complex transmembrane glycoprotein initially identified as a receptor for HA and a lymphocyte-homing receptor31, 32, 34, which is involved in many processes, including cellular adhesion, angiogenesis, inflammation and tumour development32, 34. Here, CD44 is linked to neoplasm.